In the treatment of small renal masses, robotic partial nephrectomy (RPN) has a superior morbidity profile compared with laparoscopic partial nephrectomy (LPN), according to an updated meta-analysis ...

Safety and efficacy outcomes with nivolumab plus ipilimumab in patients with advanced renal cell carcinoma and brain metastases: results from the CheckMate 920 trial. Neoadjuvant atezolizumab (A) with ...

Prediction of response to sunitinib in patients with advanced renal cell carcinoma (RCC) using mass spectrometry-based (phospho) proteomics. This is an ASCO Meeting Abstract from the 2021 ASCO Annual ...

University of Iowa Health announced in early February 2026 that it had successfully completed its first robotic living donor nephrectomy ...

Indications for nephrectomy (including nephroureterectomy) include benign and malignant tumours; conditions that damage renal function such as chronic infection; and donation for transplantation. For ...

Partial and radical nephrectomy for T3a RCC have similar 5-year rates of overall and cancer-specific survival, according to a propensity score-matched analysis. WASHINGTON, DC—Partial nephrectomy (PN) ...

Patients with renal-cell carcinoma who undergo nephrectomy have no options for adjuvant therapy to reduce the risk of recurrence that have high levels of supporting evidence. In a double-blind, phase ...

Patients with renal-cell carcinoma who undergo nephrectomy have few options for adjuvant therapy to reduce the recurrence risk; nearly half will eventually have recurrence and substantially shortened ...

A minimally invasive approach does not increase risk for atypical sites of kidney cancer recurrence, a recent study suggests. Partial nephrectomy for renal cell carcinoma (RCC) with a minimally ...